التفاصيل البيبلوغرافية
| العنوان: |
661 Initial results from a phase 1a/b study of IK-175, an oral AHR inhibitor, as a single agent and in combination with nivolumab in patients with advanced solid tumors and urothelial carcinoma |
| المؤلفون: |
Aggen, David, McKean, Meredith, Lakhani, Nehal, Bashir, Babar, Hoffman-Censits, Jean, Alhalabi, Omar, Guancial, Elizabeth, Bowman, Isaac, Tan, Alan, Lingaraj, Trupti, Timothy, Marissa, Ortiz-Otero, Nerymar, Bartolini, Wilmin, Kacena, Katherine, Malek, Karim, Santillana, Sergio, Luke, Jason |
| المصدر: |
Regular and Young Investigator Award Abstracts |
| بيانات النشر: |
BMJ Publishing Group Ltd |
| سنة النشر: |
2022 |
| نوع الوثيقة: |
conference object |
| اللغة: |
unknown |
| DOI: |
10.1136/jitc-2022-sitc2022.0661 |
| DOI: |
10.1136/jitc-2022-SITC2022.0661 |
| الإتاحة: |
https://doi.org/10.1136/jitc-2022-sitc2022.0661Test |
| رقم الانضمام: |
edsbas.48286926 |
| قاعدة البيانات: |
BASE |
